Gibson Dunn advises Quidel Corporation on its US$6 billion acquisition of Ortho Clinical Diagnostics, with Latham & Watkins advising Ortho Clinical Diagnostics.
Ortho Clinical Diagnostics Holdings plc sold the stake/assets to Quidel Corporation as part of a acquisition on 2021-12-23.
Deal value was 60000000000 (source: Extracted) Seller position: 100% acquisition; Sector: Healthcare; Location: Global.
On the seller side, Latham & Watkins advised, led by David Brown, Bradley Faris, Richard Butterwick, Jeffrey Chenard, Scott Forchheimer.
Generated by AI, original source from - Data is in progress
Found it useful? Spread the word.
Gibson Dunn advises Quidel Corporation on its US$6 billion acquisition of Ortho Clinical Diagnostics, with Latham & Watkins advising Ortho Clinical Diagnostics. | The Sponsor - The Sponsor
